Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             28 results found
no title author magazine year volume issue page(s) type
1 A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis Kobayashi, Shigeto
2011
22 4 p. 589-597
article
2 Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140/MDA5 autoantibodies Sato, Shinji

22 4 p. 625-629
article
3 Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140/MDA5 autoantibodies Sato, Shinji
2011
22 4 p. 625-629
article
4 Clinical significance of serum levels of secretory leukocyte protease inhibitor in patients with systemic sclerosis Aozasa, Naohiko
2011
22 4 p. 576-583
article
5 Comment on “Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks” by Yokoe et al. Nagashima, Takao
2012
22 4 p. 638-639
article
6 Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis: systemic arthritis and polyarthritis Ozawa, Remi
2011
22 4 p. 558-564
article
7 Development of germinoma during the treatment of systemic-onset juvenile idiopathic arthritis with infliximab Takezaki, Shunichiro
2011
22 4 p. 621-624
article
8 Effects of APRIL (TNFSF13) polymorphisms and splicing isoforms on the secretion of soluble APRIL Furuya, Takumi
2011
22 4 p. 541-549
article
9 Erratum to: Lack of association of Toll-like receptor 9 polymorphisms with susceptibility to systemic lupus erythematosus in an Asian population: a meta-analysis Li, Jing
2012
22 4 p. 557
article
10 Erratum to: Reply to: Comment on ‘‘Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks’’ by Yokoe et al. Yokoe, Isamu
2012
22 4 p. 643
article
11 Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan Yokota, Shumpei
2012
22 4 p. 491-497
article
12 High serum matrix metalloproteinase 3 is characteristic of patients with paraneoplastic remitting seronegative symmetrical synovitis with pitting edema syndrome Origuchi, Tomoki
2011
22 4 p. 584-588
article
13 Hydronephrosis caused by a relapse of granulomatosis with polyangiitis (Wegener’s) Umemoto, Azusa
2011
22 4 p. 616-620
article
14 Improvement of endothelial function in parallel with the amelioration of dry cough and dyspnea due to interstitial pneumonia by intravenous cyclophosphamide pulse therapy in patients with systemic sclerosis: a preliminary report of two cases Takahashi, Takehiro
2011
22 4 p. 598-601
article
15 Influence of antibodies against infliximab and etanercept on the treatment effectiveness of these agents in Japanese patients with rheumatoid arthritis Hoshino, Motoaki
2011
22 4 p. 532-540
article
16 Lack of association of Toll-like receptor 9 polymorphisms with susceptibility to systemic lupus erythematosus in an Asian population: a meta-analysis Li, Jing
2012
22 4 p. 550-556
article
17 Morphea associated with the use of adalimumab: a case report and review of the literature Ramírez, Julio
2011
22 4 p. 602-604
article
18 Positional occlusion of the vertebral artery in a case of rheumatoid atlantoaxial subluxation presenting with multiple cerebral and cerebellar infarction Fujiwara, Hiroyasu
2011
22 4 p. 605-609
article
19 Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (RA) and non-RA rheumatic diseases Yoshida, Yuji
2011
22 4 p. 509-514
article
20 Prospective monitoring of Epstein–Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab Kawada, Jun-ichi
2011
22 4 p. 565-570
article
21 Radiographic remodeling of the shoulder joint in a patient with rheumatoid arthritis after 4 years of treatment with etanercept Ozaki, Toshifumi
2012
22 4 p. 635-637
article
22 Reply to: Comment on “Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks” by Yokoe et al. Yokoe, Isamu
2012
22 4 p. 640-642
article
23 Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients Koike, Takao
2011
22 4 p. 498-508
article
24 Smoking is associated with an increased risk of developing ACPA-positive but not ACPA-negative rheumatoid arthritis in Asian populations: evidence from the Malaysian MyEIRA case–control study Yahya, Abqariyah
2011
22 4 p. 524-531
article
25 The rapid efficacy of abatacept in a patient with rheumatoid vasculitis Fujii, Wataru
2011
22 4 p. 630-634
article
26 The role of resistin in Behçet’s disease: a Turkish experiment Pehlivan, Yavuz
2011
22 4 p. 571-575
article
27 Three cases of pneumatosis intestinalis presenting in autoimmune diseases Sagara, Akihiro
2011
22 4 p. 610-615
article
28 Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms Mori, Shunsuke
2011
22 4 p. 515-523
article
                             28 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands